Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-049929
Filing Date
2021-12-28
Accepted
2021-12-28 16:30:24
Documents
1
Period of Report
2021-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4185
  Complete submission text file 0000899243-21-049929.txt   5652
Mailing Address 1001 SANTERRE DRIVE GRAND PRAIRIE TX 75050
Business Address
AUERBACH MARK (Reporting) CIK: 0001018007 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 211525299

Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415 877 4887
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations